 CAMBRIDGE, Mass., Feb. 11, 2022 GLOBE NEWSWIRE -- Vor Biopharma Nasdaq: VOR, a clinical-stage cell and genome engineering company, today announced that Dr. Robert Ang, Vors President and Chief Executive Officer, will present virtually at the 11th Annual SVB Leerink Global Healthcare Conference. 